Literature DB >> 17251400

Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.

Workenesh Ayele1, Rob Schuurman, Tsehaynesh Messele, Wendelien Dorigo-Zetsma, Yohannes Mengistu, Jaap Goudsmit, William A Paxton, Michel P de Baar, Georgios Pollakis.   

Abstract

We studied the use of dried spots of bodily fluids (plasma, whole blood, and mother's milk) on filter paper as a means of sample collection and storage for human immunodeficiency virus type 1 (HIV-1) viral load testing under stringent field conditions. Plasma placed directly in lysis buffer, which is customarily used for viral load assays, was used for comparison in all our experiments. Utilizing reconstruction experiments, we demonstrate no statistical differences between viral loads determined for plasma and mother's milk spotted on filter paper and those for the same fluids placed directly in lysis buffer. We found that the addition of whole blood directly to lysis buffer was unreliable and could not be considered a feasible option. However, viral load measurements for whole blood spotted onto filter paper correlated with plasma viral load values for both filter spots and lysis buffer (Pearson correlation coefficients, 0.7706 and 0.8155, respectively). In conclusion, dried spots of plasma, whole blood, or mother's milk provide a feasible means for the collection, storage, and shipment of samples for subsequent viral load measurement and monitoring. Virus material spotted and dried on filter paper is a good inexpensive alternative for collecting patient material to monitor the HIV-1 viral load. Measuring the HIV-1 burden from whole blood dried on filter paper provides a suitable alternative for low-technology settings with limited access to refrigeration, as can be found in sub-Saharan Africa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251400      PMCID: PMC1829137          DOI: 10.1128/JCM.01919-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

Review 1.  The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs.

Authors:  J S Murray; M R Elashoff; L C Iacono-Connors; T A Cvetkovich; K A Struble
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

Review 2.  HIV viral load markers in clinical practice.

Authors:  M S Saag; M Holodniy; D R Kuritzkes; W A O'Brien; R Coombs; M E Poscher; D M Jacobsen; G M Shaw; D D Richman; P A Volberding
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

3.  Identification of a site for a cohort study on natural history of HIV infection in Ethiopia.

Authors:  T Sahlu; A Fontanet; T Rinke de Wit; T Messele; R Doorly; H Yeneneh; P Bindels; R Coutinho
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-02-01

4.  Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper.

Authors:  S A Fiscus; D Brambilla; L Grosso; J Schock; M Cronin
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology.

Authors:  S Cassol; B G Weniger; P G Babu; M O Salminen; X Zheng; M T Htoon; A Delaney; M O'Shaughnessy; C Y Ou
Journal:  AIDS Res Hum Retroviruses       Date:  1996-10-10       Impact factor: 2.205

6.  Subtype-specific problems with quantification of plasma HIV-1 RNA.

Authors:  A Alaeus; K Lidman; A Sönnerborg; J Albert
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

7.  Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.

Authors:  I C Marschner; A C Collier; R W Coombs; R T D'Aquila; V DeGruttola; M A Fischl; S M Hammer; M D Hughes; V A Johnson; D A Katzenstein; D D Richman; L M Smeaton; S A Spector; M S Saag
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

8.  AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.

Authors:  F de Wolf; I Spijkerman; P T Schellekens; M Langendam; C Kuiken; M Bakker; M Roos; R Coutinho; F Miedema; J Goudsmit
Journal:  AIDS       Date:  1997-12       Impact factor: 4.177

9.  Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper.

Authors:  S Cassol; M J Gill; R Pilon; M Cormier; R F Voigt; B Willoughby; J Forbes
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

10.  Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA.

Authors:  D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

View more
  15 in total

1.  HIV load testing with small samples of whole blood.

Authors:  Katrin Steinmetzer; Thomas Seidel; Andreas Stallmach; Eugen Ermantraut
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.

Authors:  Kim Steegen; Stanley Luchters; Els Demecheleer; Kenny Dauwe; Kishor Mandaliya; Walter Jaoko; Jean Plum; Marleen Temmerman; Chris Verhofstede
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

3.  Development and evaluation of a one step reverse transcription-loop mediated isothermal amplification assay (RT-LAMP) for rapid detection of foot and mouth disease virus in India.

Authors:  Rajeev Ranjan; Muniswamy Kangayan; Saravanan Subramaniam; Jajati K Mohapatra; Jitendra K Biswal; Gaurav K Sharma; Aniket Sanyal; Bramhadev Pattnaik
Journal:  Virusdisease       Date:  2014-04-13

4.  Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA Qualitative Assay.

Authors:  C Thomas Nugent; J Dockter; F Bernardin; R Hecht; D Smith; E Delwart; C Pilcher; D Richman; M Busch; C Giachetti
Journal:  J Virol Methods       Date:  2009-02-24       Impact factor: 2.014

5.  Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing.

Authors:  R M Lloyd; D A Burns; J T Huong; R L Mathis; M A Winters; M Tanner; A De La Rosa; B Yen-Lieberman; W Armstrong; A Taege; D R McClernon; J L Wetshtein; Brian M Friedrich; Monique R Ferguson; William O'Brien; P M Feorino; M Holodniy
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

6.  Monitoring HIV vaccine trial participants for primary infection: studies in the SIV/macaque model.

Authors:  James B Whitney; Corinne Luedemann; Saran Bao; Ayako Miura; Srinivas S Rao; John R Mascola; Norman L Letvin
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

7.  Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.

Authors:  Charlotte H Lenselink; Roosmarie P de Bie; Dennis van Hamont; Judith M J E Bakkers; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

8.  Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.

Authors:  J Fachiroh; P R Prasetyanti; D K Paramita; A T Prasetyawati; D W Anggrahini; S M Haryana; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2008-02-06       Impact factor: 5.948

9.  Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.

Authors:  Carolina Garrido; Natalia Zahonero; Angélica Corral; Miguel Arredondo; Vincent Soriano; Carmen de Mendoza
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

10.  Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing.

Authors:  Marjorie Monleau; Céline Montavon; Christian Laurent; Michel Segondy; Brigitte Montes; Eric Delaporte; François Boillot; Martine Peeters
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.